Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2010 2
2011 2
2013 1
2014 2
2016 1
2018 1
2019 1
2020 4
2021 4
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Derdeyn CP, et al. Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26. Lancet. 2014. PMID: 24168957 Free PMC article. Clinical Trial.
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome.
Okuda DT, Kantarci O, Lebrun-Frénay C, Sormani MP, Azevedo CJ, Bovis F, Hua LH, Amezcua L, Mowry EM, Hotermans C, Mendoza J, Walsh JS, von Hehn C, Vargas WS, Donlon S, Naismith RT, Okai A, Pardo G, Repovic P, Stüve O, Siva A, Pelletier D. Okuda DT, et al. Among authors: okai a. Ann Neurol. 2023 Mar;93(3):604-614. doi: 10.1002/ana.26555. Epub 2022 Dec 10. Ann Neurol. 2023. PMID: 36401339 Clinical Trial.
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ; PREVENT Study Group. Wingerchuk DM, et al. Ann Neurol. 2021 Jun;89(6):1088-1098. doi: 10.1002/ana.26049. Epub 2021 Feb 27. Ann Neurol. 2021. PMID: 33586143 Free PMC article. Clinical Trial.
Stenting versus aggressive medical therapy for intracranial arterial stenosis.
Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators. Chimowitz MI, et al. N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7. N Engl J Med. 2011. PMID: 21899409 Free PMC article. Clinical Trial.
Genetic mapping of Uba3 O.2.2 , a pupal lethal mutation in Drosophila melanogaster.
Mast E, Bieser KL, Abraham-Villa M, Adams V, Akinlehin AJ, Aquino LZ, Austin JL, Austin AK, Beckham CN, Bengson EJ, Bieszk A, Bogard BL, Brennan RC, Brnot RM, Cirone NJ, Clark MR, Cooper BN, Cruz D, Daprizio KA, DeBoe J, Dencker MM, Donnelly LL, Driscoll L, DuBeau RJ, Durso SW, Ejub A, Elgosbi W, Estrada M, Evins K, Fox PD, France JM, Franco Hernandez MG, Garcia LA, Garl O, Gorsuch MR, Gorzeman-Mohr MA, Grothouse ME, Gubbels ME, Hakemiamjad R, Harvey CV, Hoeppner MA, Ivanov JL, Johnson VM, Johnson JL, Johnson A, Johnston K, Keller KR, Kennedy BT, Killian LR, Klumb M, Koehn OL, Koym AS, Kress KJ, Landis RE, Lewis KN, Lim E, Lopez IK, Lowe D, Luengo Carretero P, Lunaburg G, Mallinder SL, Marshall NA, Mathew J, Mathew J, Mcmanaway HS, Meegan EN, Meyst JD, Miller MJ, Minogue CK, Mohr AA, Moran CI, Moran A, Morris MD, Morrison MD, Moses EA, Mullins CJ, Neri CI, Nichols JM, Nickels BR, Okai AM, Okonmah C, Paramo M, Paramo M, Parker SL, Parmar NK, Paschal J, Patel P, Patel D, Perkins EB, Perry MM, Perry Z, Pollock AA, Portalatin O, Proffitt KS, Queen JT, Quemeneur AC, Richardson AG, Rosenberger K, Rutherford AM, Santos-Perez IX, Sarti CY, Schouweiler LJ, Sessing LM, Setaro SO, Sil… See abstract for full author list ➔ Mast E, et al. Among authors: okai am. MicroPubl Biol. 2022 Mar 18;2022:10.17912/micropub.biology.000542. doi: 10.17912/micropub.biology.000542. eCollection 2022. MicroPubl Biol. 2022. PMID: 35622528 Free PMC article.
28 results